Content about Macula of retina

January 29, 2013
Wills Eye Institute: Incidence linking aspirin to macular degeneration too low to stop aspirin therapy

"Talk to your cardiologist." That's the advice offered last week by Wills Eye Institute, a hospital specializing in eye care, following a JAMA article linking aspirin therapy to macular degeneration.

PHILADELPHIA — "Talk to your cardiologist." That's the advice offered Friday by Wills Eye Institute, a hospital specializing in eye care,  following a JAMA article linking aspirin therapy to macular degeneration. 

October 18, 2012
FDA approves first drug for eye condition

The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

The agency announced the approval of Jetrea (ocriplasmin), made by Iselin, N.J.-based ThromboGenics. The drug is used to treat symptomatic vitreomacular adhesion.

September 24, 2012
FDA approves Regeneron drug for macular edema

The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

TARRYTOWN, N.Y. — The Food and Drug Administration has approved a drug for treating a complication of a disease that results from vein blockages in the eye.

Regeneron Pharmaceuticals announced the approval of Eylea (aflibercept) for treating macular edema following central retinal vein occlusion, or CRVO. Eylea already was approved for treating neovascular age-related macular degeneration, another eye disease.